RDB01489 - pBluescript SKII+hIL2

Please review the QC test results indicated by check

icon below as well as clone information before placing your order.

pBluescript SKII+hIL2 (#RDB01489)

Plasmid clone of human IL-2 cDNA

Alternative name	Human IL2 cDNA
Clone info.	Human IL2 cDNA
Vector backbone	pBluescript II SK (+) (Plasmid)
Size of vector backbone	3.0 kb
Selectable markers	Amp^r
Gene/insert name	Human IL-2 cDNA
Depositor\|Developer	Hamada, Hirofumi \|

Additional map

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link]

Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.

提供案内 (日本国内) [open/close]

Ordering forms	Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link]
Terms and conditions for distribution	The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.

必要書類	提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件	非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。

必要書類

提供依頼書

[依頼書の記入例

]
提供同意書 (MTA, 非営利学術目的用)[Word

] [MTAの記入例

]
手続きの概要は、「提供申込みについて[link]」をご覧ください。

MTAに書く使用条件

非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。

Catalog #	Resource name	Shipping form	Fee (non-profit org.)
RDB01489	pBluescript SKII+hIL2	DNA solution	Please contact us.

Please review the QC test results indicated by check

icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pBluescript SKII+hIL2 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01489).

Reference section:

Further references such as user reports and related articles (go to bottom)

QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet	RDB19828_B2Lkp1-2.pdf

Nucleotide sequence of a portion of this resource (if available).

Primer: M13ori_R1 (Pr1087) Region: f1 ori,T7 pro,insert 5' Sequence file: RDB19828_B2Lka.seq
>01489_19828_B2Lk_1_M13ori_R1_C03_09_ABI24.ab1 1 NNNNNNNNNN NNGNNGNCGN NNNNNAAGGG AAGANGCGAA AGGAGCGGGC GCTAGGGCGC 61 TGGCAAGTGT AGCGGTCACG CTGCGCGTAA CCACCACACC CGCCGCGCTT AATGCGCCGC 121 TACAGGGCGC GTCCCATTCG CCATTCAGGC TGCGCAACTG TTGGGAAGGG CGATCGGTGC 181 GGGCCTCTTC GCTATTACGC CAGCTGGCGA AAGGGGGATG TGCTGCAAGG CGATTAAGTT 241 GGGTAACGCC AGGGTTTTCC CAGTCACGAC GTTGTAAAAC GACGGCCAGT GAGCGCGCGT 301 AATACGACTC ACTATAGGGC GAATTGGGTA CCGGGCCCCC CCTCGAGGTC GACGGTATCG 361 ATAAGCTTGA TATCGAATTC GCTAGCTACC ATGTACAGGA TGCAACTCCT GTCTTGCATT 421 GCACTAAGTC TTGCACTTGT CACAAACAGT GCACCTACTT CAAGTTCTAC AAAGAAAACA 481 CAGCTACAAC TGGAGCATTT ACTTCTGGAT TTACAGATGA TTTTGAATGG AATTAATAAT 541 TACAAGAATC CCAAACTCAC CAGGATGCTC ACATTTAAGT TTTACATGCC CAAGAAGGCC 601 ACAGAACTGA AACATCTTCA GTGTCTAGAA GAAGAACTCA AACCTCTGGA GGAAGTGCTA 661 AATTTAGCTC AAAGCAAAAA CTTTCACTTA AGACCCAGGG ACTTAATCAG CAATATCAAC 721 GTAATAGTTC TGGAACTAAA GGGATCTGAA ACAACATTCA TGTGTGAATA TGCTGATGAG 781 ACAGCAACCA TTGTAGAATT TCTGANCAGA TGGATTACCT TTTGTCAAAG CATCATCTCA 841 ACACTGACTT GAATTNCTGC AGCCCGGGGG ATCCACTAGT TCTAGAGCGG NNGCNACNGC 901 GGNGGANCTN CNGCTTTTGT NNCCTTNANN GAGGGTNNAT TGNGCGCTTG GCGNANNCNT 961 GGNCATANCT GNTNNCTGNG TGAAATTGNN NTCCNNTCNN NNNTCCNCNN NNCATACNAN 1021 CNNGNANNNT AAAGNGNAAN NNCNGNNNNN NCNNANNNNN NNNNN //
Primer: M13_-40 (Pr0410) Region: insert Sequence file: RDB19828_B2Lkb.seq
>01489_19828_B2Lk_1_M13_-40_B03_06_ABI24.ab1 1 NNNNNNNNNN NCTATAGGGC GAANTGGNTA CCGGGCCCCC CCTCGAGGTC GACGGTATCG 61 ATAAGCTTGA TATCGAATTC GCTAGCTACC ATGTACAGGA TGCAACTCCT GTCTTGCATT 121 GCACTAAGTC TTGCACTTGT CACAAACAGT GCACCTACTT CAAGTTCTAC AAAGAAAACA 181 CAGCTACAAC TGGAGCATTT ACTTCTGGAT TTACAGATGA TTTTGAATGG AATTAATAAT 241 TACAAGAATC CCAAACTCAC CAGGATGCTC ACATTTAAGT TTTACATGCC CAAGAAGGCC 301 ACAGAACTGA AACATCTTCA GTGTCTAGAA GAAGAACTCA AACCTCTGGA GGAAGTGCTA 361 AATTTAGCTC AAAGCAAAAA CTTTCACTTA AGACCCAGGG ACTTAATCAG CAATATCAAC 421 GTAATAGTTC TGGAACTAAA GGGATCTGAA ACAACATTCA TGTGTGAATA TGCTGATGAG 481 ACAGCAACCA TTGTAGAATT TCTGAACAGA TGGATTACCT TTTGTCAAAG CATCATCTCA 541 ACACTGACTT GAATTCCTGC AGCCCGGGGG ATCCACTAGT TCTAGAGCGG CCGCCACCGC 601 GGTGGAGCTC CNGCTTTTGN TCCCTTTAGT GAGGNNTAAT TGCGCGCTTG GCGTAATCAT 661 GGTCATAGCT GTTTCCTGTG TGAAATTGNT ATCCGCTCAC NATTCCACAC NACATACNAN 721 CCGGNNCATN ANNTGNAAAG CCTGGGGGTG NCTNANGAGT GAGCTNACTC ACANTAATTG 781 NNTTGCGCTC ACTGNCCGCT TTNCNGTCNG GAAANCNGNC NNGNCNNCTG NNTTAATGNA 841 TCGGCCNACG CGCGGGNNNA NGNGGTTTGN GTANNNNNNC TNNNNCNNTN NCNCNNNCAC 901 TGNNTCNNTG CGCTNNGNCG NNCNNNTGNN NNNANNNNNN NCNNNTNNNT CNNNNNNNNN 961 N //